Clene (CLNN) Total Liabilities (2019 - 2026)
Clene (CLNN) posted Total Liabilities of $47.8 million for Q2 2026, up 33.86% on a QoQ basis from $35.7 million in Q4 2025, and up 55.89% year-over-year from $30.7 million in Q2 2025.
Analysis
Clene (CLNN) Total Liabilities (2019 - 2026) Analysis & Trends
Clene has reported Total Liabilities for 8 years, with the latest figure at $47.8 million in Q2 2026.
- On a quarterly basis, Total Liabilities rose 55.89% year-over-year to $47.8 million in Q2 2026; TTM through Jun 2026 was $47.8 million, a 55.89% increase from a year earlier, with the FY2025 full-year figure at $35.7 million, down 1.3% from the prior year.
- Total Liabilities was $47.8 million for Q2 2026 at Clene, up from $35.7 million in the prior quarter.
- The five-year high for Total Liabilities was $51.3 million in Q1 2022, with the low at $30.3 million in Q1 2025.
- Average Total Liabilities over 5 years is $40.1 million, with a median of $40.8 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Total Liabilities plunged 54.54% in 2022, then surged 55.89% in 2026.
- Over 5 years, Total Liabilities stood at $41.3 million in 2022, then declined by 5.59% to $39.0 million in 2023, then slipped by 7.08% to $36.2 million in 2024, then slipped by 1.3% to $35.7 million in 2025, then jumped by 33.86% to $47.8 million in 2026.
- The last three Total Liabilities figures came in at $47.8 million (Q2 2026), $35.7 million (Q4 2025), and $34.7 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 23.74 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 115.64 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 69.15 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 1.72 Bn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 1.53 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 819.80 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | 47.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.82 Mn |
| Dec 31, 2025 | 35.72 Mn |
| Sep 30, 2025 | 34.67 Mn |
| Jun 30, 2025 | 30.68 Mn |
| Mar 31, 2025 | 30.29 Mn |
| Dec 31, 2024 | 36.19 Mn |
| Sep 30, 2024 | 35.69 Mn |
| Jun 30, 2024 | 40.83 Mn |
| Mar 31, 2024 | 40.81 Mn |
| Dec 31, 2023 | 38.95 Mn |
| Sep 30, 2023 | 39.03 Mn |
| Jun 30, 2023 | 46.31 Mn |
| Mar 31, 2023 | 41.52 Mn |
| Dec 31, 2022 | 41.26 Mn |
| Sep 30, 2022 | 45.32 Mn |
| Jun 30, 2022 | 45.11 Mn |
| Mar 31, 2022 | 51.34 Mn |
| Dec 31, 2021 | 50.47 Mn |
| Sep 30, 2021 | 67.35 Mn |
| Jun 30, 2021 | 99.21 Mn |